Zdrowie i gospodarka · 01/06/2004

FDA Reopens Comment Period for Draft Guidances on Medical Product and Health Condition Information

The Food and Drug Administration (FDA) is reopening the comment period for three draft guidances until August 10, 2004, in response to requests for an extension, allowing interested parties more time to submit comments. The draft guidances focus on disclosing risk information in advertisements and disease awareness communications.